Edward J Sitar is Director of Timber Pharmaceuticals, Inc.. Currently has a direct ownership of 11,127 shares of TMBR, which is worth approximately $0. The most recent transaction as insider was on Apr 15, 2023, when has been sold 5,327 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.1K
0% 3M change
0% 12M change
Total Value Held $0

Edward J Sitar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2023
BUY
Grant, award, or other acquisition
-
5,327 Added 32.38%
11,127 Common Stock, par valu...
Dec 15 2022
BUY
Grant, award, or other acquisition
$4,074 $1.63 p/Share
2,500 Added 30.12%
5,800 Common Stock, par valu...
Apr 15 2022
BUY
Grant, award, or other acquisition
-
150,000 Added 47.62%
165,000 Common Stock, par valu...
Nov 23 2021
BUY
Open market or private purchase
$6,900 $0.46 p/Share
15,000 Added 50.0%
15,000 Common Stock, par valu...

Also insider at

VYNT
Vyant Bio, Inc. Healthcare
NMTR
9 METERS BIOPHARMA, INC. Healthcare
EJS

Edward J Sitar

Director
Rutherford, NJ

Track Institutional and Insider Activities on TMBR

Follow Timber Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMBR shares.

Notify only if

Insider Trading

Get notified when an Timber Pharmaceuticals, Inc. insider buys or sells TMBR shares.

Notify only if

News

Receive news related to Timber Pharmaceuticals, Inc.

Track Activities on TMBR